William R. Ringo

CIK: 0001238325

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ASMB

ASSEMBLY BIOSCIENCES, INC.

Director

SNSE

Sensei Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ASMB
ASSEMBLY BIOSCIENCES, INC.
Jun 5, 2025
Award(A)
Stock Option (right to buy)
Direct
3.5K shares-
SNSE
Sensei Biotherapeutics, Inc.
May 21, 2025
Award(A)
Stock Option (Right to Buy)
Direct
19K shares-

		Type	Shares	Price		Ownership
Jun 5, 2025	ASMB ASSEMBLY BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	3,500	-	-	Direct
May 21, 2025	SNSE Sensei Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	19,000	-	-	Direct

1-2 of 2 transactions

About RINGO WILLIAM R

RINGO WILLIAM R (SEC CIK 0001238325) files insider reports with the SEC as Director of ASSEMBLY BIOSCIENCES, INC. (ASMB) and Director of Sensei Biotherapeutics, Inc. (SNSE).

Signal8 holds 2 ownership filings by RINGO WILLIAM R, all Form 4s, filed between May 23, 2025 and Jun 9, 2025. Those filings report 2 transactions, from May 21, 2025 to Jun 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on RINGO WILLIAM R's filings is in ROCKVILLE, MD.

Recent filings by RINGO WILLIAM R

Jun 5, 2025: Grant or award of ASMB derivative securities (Form 4, code A).
May 21, 2025: Grant or award of SNSE derivative securities (Form 4, code A).

Other insiders filing for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Bjorkquist Jeanette M, PFO and PAO
Gaggar Anuj, Chief Medical Officer
White Nicole S, Chief Manufacturing Officer
McHutchison John G, Director
Mahony Susan, Director
Johnson-Pratt Lisa, Director

How to read Form 4 transaction codes